Comparing the Long-term Cost-effectiveness of Repaglinide Plus Metformin Versus Nateglinide Plus Metformin in Type 2 Diabetes Patients with Inadequate Glycaemic Control: An Application of the CORE Diabetes Model in Type 2 Diabetes

Palmer, A. J. et al.

Current medical research and opinion. VOL 20; SUPP/1, ; 2004, S41-S52 -- LIBRA PHARM LTD (pages S41-S52) -- 2004

Check library holdings